ArticleActa pharmacologica Sinica2022

Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.

Lu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.